National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Sipuleucel-T (SY-puh-LOO-sel...)

 A vaccine made from immune system cells collected from a patient with prostate cancer. The cells are treated in the laboratory with a growth factor attached to a protein found on prostate cancer cells. Sipuleucel-T injected into patients may stimulate T lymphocytes to kill tumor cells that express the prostate protein. Also called APC8015 and Provenge.



Previous Definitions:single blind study, single nucleotide polymorphism, single-photon emission computed tomography, Singulair, siplizumab
Next Definitions:sirolimus, SIRS, SJG-136, Sjögren syndrome, SK&F106615

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov